The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol Dmel\CG18547 is not ambiguous in the evidence retrieved: it refers to Drosophila melanogaster CG18547, FlyBase FBgn0037973, whose protein product is UniProt Q9VGF3. The literature’s recurring annotation—“NAD(P)-linked oxidoreductase”—agrees with the supplied UniProt/InterPro/Pfam assignments to the aldo-keto reductase-like PF00248 fold. No conflicting same-symbol gene from another organism was used in this report. A genetic insertion named P{XP}CG18547 encountered in unrelated work should not be mistaken for evidence that CG18547 has the function of the locus being engineered.
The principal finding is nevertheless an evidence gap: CG18547 has not been biochemically characterized. No retrieved study establishes its physiological substrate, product, EC reaction, kinetic constants, preferred cofactor, protein-level subcellular localization, loss-of-function phenotype, or membership in a defined biochemical/signaling pathway. The strongest direct evidence instead identifies its transcript as a marker of a GST-rich larval lymph-gland cell state and places CG18547-expressing cells near the outer boundary of Tep4-positive prohemocytes. Other transcriptomic studies connect its expression to dietary and developmental perturbations, but do not establish mechanism. (jaligam2004developmentalprogrammedcell pages 29-32, cho2020singlecelltranscriptomemaps pages 5-6, kharrat2022peelingbackthe pages 6-7)
Verified target
An independent Drosophila gene table maps CG18547 to FBgn0037973 and labels its molecular activity “oxidoreductase activity” and its product an “NAD(P)-linked oxidoreductase.” This agrees with, rather than contradicts, the supplied UniProt identity and PF00248 assignment. However, that source reports an annotation, not a biochemical assay of Q9VGF3. (jaligam2004developmentalprogrammedcell pages 29-32)
Identity verdict: the correct protein has been researched, but literature for this specific protein is limited. The appropriate formulation is therefore: “The literature is limited for Dmel\CG18547/Q9VGF3; its function can presently be inferred only at the broad AKR-family level.”
Aldo-keto reductases are widely distributed oxidoreductases. Their most common chemistry is hydride transfer between NADP(H) and carbonyl-containing substrates such as aldehydes, ketones, and quinones, although individual AKRs can act on chemically unusual substrates. Canonical members generally possess an eight-stranded (α/β)8 TIM-barrel, a conserved NADPH-binding architecture, and a catalytic Tyr-Asp-Lys-His framework. In the usual reductive reaction, NADPH contributes the 4-pro-R hydride while catalytic tyrosine supplies a proton; the other tetrad residues tune proton transfer and substrate orientation. (carr2024twoubiquitousaldoketo pages 3-5, xiao2024athreelevelregulatory pages 1-2, abraham2024structuralandfunctional pages 131-138)
Accordingly, the most defensible working hypothesis for Q9VGF3 is:
carbonyl compound + NADPH + H⁺ ⇌ corresponding alcohol + NADP⁺
This is a family-level reaction template, not an experimentally demonstrated CG18547 reaction. Some AKRs accept both NADH and NADPH, and catalytic direction depends on substrate/product concentrations and cellular redox conditions. Cofactor preference must therefore be measured rather than assumed from PF00248 alone. (xiao2024athreelevelregulatory pages 3-4, abraham2024structuralandfunctional pages 41-47)
The AKR substrate pocket is formed substantially by variable loops and can be highly promiscuous. Recent structural work shows that closely related AKRs can process different specialized metabolites and can display allostery, substrate cooperativity, or inhibition at high NADPH concentrations. Thus, sequence/domain membership identifies a broad catalytic scaffold but not the physiological substrate. (carr2024twoubiquitousaldoketo pages 3-5, xiao2024athreelevelregulatory pages 3-4, xiao2024athreelevelregulatory pages 1-2, xiao2024athreelevelregulatory pages 2-3)
The LGALDH-like annotation should likewise be interpreted as structural/evolutionary similarity, not proof that Q9VGF3 is an L-galactose dehydrogenase or participates in plant-type ascorbate biosynthesis. No retrieved Drosophila study demonstrated oxidation of L-galactose or any other named substrate by Q9VGF3.
At present, CG18547 should be annotated conservatively as a putative NADP(H)-dependent AKR-like oxidoreductase. Its exact reaction and substrate specificity are unknown. Plausible broad roles include reactive-carbonyl detoxification, redox homeostasis, or small-molecule metabolism, but none is established specifically for CG18547. AKRs elsewhere participate in detoxification, carbon assimilation, iron acquisition, and specialized-metabolite biosynthesis, illustrating why family membership alone does not select among these possibilities. (carr2024twoubiquitousaldoketo pages 3-5, diazviraque2023newinsightsinto pages 8-11)
Cho et al. published a single-cell transcriptomic map of Drosophila myeloid blood-cell lineages in September 2020 (Nature Communications; https://doi.org/10.1038/s41467-020-18135-y). Their analysis resolved 17 lymph-gland hemocyte subclusters; CG18547 appeared in the marker analysis and, together with CG3397, was identified as a specific marker of a GST-rich cluster. CG18547 mRNA was visualized in vivo at the outer demarcation of Tep4-positive prohemocytes, providing spatial transcript-level validation rather than merely computational cluster assignment. No CG18547-specific cell percentage, expression magnitude, or statistical value was supplied in the retrieved passage. (cho2020singlecelltranscriptomemaps pages 5-6, cho2020singlecelltranscriptomemaps pages 4-5)
A July 2022 review of lymph-gland organization (https://doi.org/10.3390/ijms23147767) also lists CG18547 and CG3397 as validated GST-rich-cluster markers. That cluster has elevated glutathione-S-transferase transcripts and has been interpreted as potentially associated with ROS-mediated stress responses. Crucially, the review states that CG18547’s function remains unknown; marker co-expression does not establish that Q9VGF3 metabolizes glutathione, ROS, or a reactive carbonyl. (kharrat2022peelingbackthe pages 6-7)
Biological-process interpretation: CG18547 is credibly associated with a specialized larval hematopoietic/prohemocyte state. A role in redox or electrophile stress is biologically plausible because of both its AKR-like domain and the GST-rich context, but remains a hypothesis requiring perturbational evidence.
A March 2019 PLOS ONE transcriptomic study (https://doi.org/10.1371/journal.pone.0213474) placed CG18547, CG3397, and CG6084 in a three-gene, male-head cluster associated with aldo/keto-reductase activity. The cluster was reported as 30–40-fold enriched and nested within a broader oxidation–reduction-process cluster. Across the experiment, males had 143 differentially expressed head genes compared with 93 in females. These totals and the 30–40-fold enrichment are cluster/global statistics, not CG18547-specific fold changes; the retrieved evidence did not provide CG18547’s direction, individual effect size, P value, or FDR. (stobdan2019highfatdiet pages 6-8)
This supports dietary and sex-dependent transcriptional responsiveness but not a defined role in lipid metabolism, obesity, or neural physiology.
In an older wing-disc microarray following friend-of-echinoid (fred) RNAi, CG18547 was categorized among miscellaneous enzymes and annotated as an NAD(P)-linked oxidoreductase. The table reports mean signals of 139 in control and 3,165 experimentally, together with a stated 5.8-fold change. Because 3,165/139 is approximately 22.8 rather than 5.8, the reported quantities may reflect transformed or otherwise differently normalized measures and should not be reinterpreted without the original analytical definition. No CG18547-specific statistic or independent in-situ validation was shown. This is evidence of transcriptional association with the perturbation, not proof of direct Fred regulation or neurogenic function. (chandra2004rolesofimmunoglobulin pages 144-146)
Two different meanings of localization must be separated:
AKRs are often soluble enzymes, but assigning Q9VGF3 to the cytosol solely from superfamily precedent would be unjustified. The place where its enzymatic reaction occurs inside the cell remains unknown.
No named metabolic or signaling pathway can presently be assigned with confidence. The evidence supports three contexts rather than pathways:
None demonstrates that CG18547 lies upstream or downstream of a particular signaling component, nor that it is required for hematopoiesis, ROS control, dietary adaptation, or wing development. The most useful pathway-level hypothesis is that Q9VGF3 contributes to NADPH-coupled small-molecule or reactive-carbonyl metabolism in stress-responsive cells. It should not yet be entered as a confirmed glutathione, lipid, carbohydrate, prostaglandin, or ascorbate-pathway enzyme. (cho2020singlecelltranscriptomemaps pages 5-6, kharrat2022peelingbackthe pages 6-7, carr2024twoubiquitousaldoketo pages 3-5)
No direct 2023–2024 functional study of CG18547 was retrieved. Recent research instead improves interpretation of its domain:
The current expert interpretation is consequently conservative: modern AKR research makes the oxidoreductase hypothesis stronger, but makes a substrate-level annotation without experiments less—not more—defensible.
There is no demonstrated biotechnology, therapeutic, agricultural, diagnostic, or screening application specific to CG18547/Q9VGF3. Its present practical value is as:
Any application as a detoxification enzyme or biocatalyst would first require expression, purification, substrate screening, kinetic characterization, and demonstration of stability and selectivity.
The table below separates direct CG18547 observations from family-level inference.
| Question/claim | Best evidence | Evidence level | Defensible conclusion | Unresolved issue |
|---|---|---|---|---|
| Identity | Literature maps CG18547 to Drosophila melanogaster FlyBase FBgn0037973 and describes the product as an NAD(P)-linked oxidoreductase (jaligam2004developmentalprogrammedcell pages 29-32). | High — identifier-level match | The target is fruit-fly CG18547, corresponding to FBgn0037973 and UniProt Q9VGF3; no similarly named protein should be substituted. | The protein remains poorly characterized despite secure identity. |
| AKR/PF00248 family annotation | CG18547 is annotated as an NAD(P)-linked oxidoreductase; current AKR research describes PF00248 proteins as generally NADP(H)-linked, TIM-barrel oxidoreductases acting on diverse carbonyl or related substrates (jaligam2004developmentalprogrammedcell pages 29-32, carr2024twoubiquitousaldoketo pages 3-5, xiao2024athreelevelregulatory pages 1-2). | Moderate — family/domain inference | CG18547 is plausibly an aldo-keto reductase-like NADP-dependent oxidoreductase. This is not direct evidence of catalysis by CG18547. | Catalytic residues, cofactor preference, fold, oligomeric state, and activity have not been tested directly. |
| Exact reaction and substrate | AKRs commonly transfer hydride between NADP(H) and aldehydes, ketones, quinones, or other diverse substrates; closely related AKRs may have different physiological substrates (carr2024twoubiquitousaldoketo pages 3-5, xiao2024athreelevelregulatory pages 3-4, abraham2024structuralandfunctional pages 41-47). | Low for CG18547 — family inference only | A generic carbonyl-reduction hypothesis is reasonable, but no exact reaction, substrate, product, EC number, kinetic constant, or in-vivo direction is established. | Requires purified-protein substrate screening, cofactor assays, metabolomics, and catalytic-mutant rescue. |
| Lymph-gland expression and position | Single-cell analysis identified CG18547 and CG3397 as markers of a GST-rich hemocyte/prohemocyte subcluster. CG18547 mRNA was visualized at the outer demarcation of Tep4-positive prohemocytes (cho2020singlecelltranscriptomemaps pages 5-6, cho2020singlecelltranscriptomemaps pages 4-5). | High — direct transcript detection and spatial validation | CG18547 is expressed in a spatially restricted GST-rich cell population at the periphery of the larval lymph-gland prohemocyte compartment. | Protein abundance and intracellular localization were not measured; marker expression does not demonstrate function. |
| Possible hemocyte redox/stress context | The GST-rich cluster contains elevated glutathione-S-transferase transcripts and has been interpreted as potentially involved in ROS-mediated stress responses; CG18547 itself remains functionally unknown (kharrat2022peelingbackthe pages 6-7). | Low-to-moderate — co-expression inference | CG18547 is a candidate marker or component of a redox/stress-associated hemocyte state, but cannot yet be assigned to glutathione metabolism or ROS detoxification. | Functional perturbation must test ROS, reactive carbonyls, glutathione status, differentiation, and immune responses. |
| High-fat-diet response | CG18547 belonged with CG3397 and CG6084 to a three-gene male-head cluster associated with aldo/keto-reductase activity. The cluster was 30–40-fold enriched and nested within a broader oxidation–reduction cluster (stobdan2019highfatdiet pages 6-8). | Moderate — high-throughput transcriptomics; cluster-level statistic | CG18547 is among male-head transcripts responsive to high-fat-diet conditions. The 30–40-fold value is cluster enrichment, not CG18547 fold change. | Gene-specific direction, fold change, adjusted P value, responding cell type, and causal role were not reported in the cited passage. |
| Response in fred-RNAi wing discs | A wing-disc microarray listed CG18547 with mean signal 139 in control versus 3,165 experimentally, together with a reported 5.8-fold change, and annotated it as an NAD(P)-linked oxidoreductase (chandra2004rolesofimmunoglobulin pages 144-146). | Low-to-moderate — single high-throughput association | CG18547 transcription was altered in the fred-RNAi context, indicating regulatory responsiveness during wing-disc perturbation. | The signal ratio and reported fold change are not arithmetically equivalent; no gene-specific statistic or independent validation was supplied, and direct Fred regulation is unproven. |
| Subcellular localization | Available spatial evidence localizes CG18547-expressing cells and mRNA, not Q9VGF3 protein within cells (cho2020singlecelltranscriptomemaps pages 5-6). | Unknown | No cytosolic, nuclear, mitochondrial, membrane, secreted, or other organellar localization can be assigned experimentally. | Endogenous protein tagging, microscopy, and biochemical fractionation are needed. |
| Phenotype and pathway | Retrieved evidence consists mainly of domain annotation, transcriptomic associations, and marker expression; no CG18547-specific loss-of-function mechanism or biochemical pathway was demonstrated (jaligam2004developmentalprogrammedcell pages 29-32, cho2020singlecelltranscriptomemaps pages 5-6, kharrat2022peelingbackthe pages 6-7). | Unknown | No specific developmental, immune, metabolic, signaling, or detoxification pathway—and no organismal phenotype—can be assigned confidently. | Targeted knockout or RNAi with rescue, tissue-specific perturbation, stress assays, and metabolomics are required. |
| 2023–2024 research status | Recent studies refine general AKR mechanisms and substrate diversity, but the retrieved literature contains no direct 2023–2024 biochemical or genetic characterization of CG18547 (carr2024twoubiquitousaldoketo pages 3-5, xiao2024athreelevelregulatory pages 3-4, xiao2024athreelevelregulatory pages 1-2, diazviraque2023newinsightsinto pages 8-11). | High confidence in evidence gap | Contemporary AKR research strengthens only the family-level hypothesis; it does not establish Q9VGF3’s physiological substrate or role. | CG18547 remains a priority for direct functional annotation. |
Table: Evidence table separating direct observations about Drosophila CG18547/Q9VGF3 from AKR-family inferences. It highlights the secure identity and expression evidence while documenting major gaps in reaction, substrate, localization, phenotype, and pathway assignment.
CG18547/Q9VGF3 is securely identified as a D. melanogaster AKR-like NADP-dependent oxidoreductase-domain protein, but its primary biochemical function remains unresolved. The best direct biological evidence places its transcript in a GST-rich lymph-gland population at the periphery of Tep4-positive prohemocytes and identifies diet- and developmental-perturbation-associated expression. These observations make redox or reactive-carbonyl metabolism a reasonable testable hypothesis, not a confirmed annotation. No physiological substrate, exact reaction, intracellular protein compartment, causal phenotype, or pathway membership should presently be asserted.
References
(jaligam2004developmentalprogrammedcell pages 29-32): V Jaligam. Developmental programmed cell death in the midline glia cells of drosophila embryo. Unknown journal, 2004.
(cho2020singlecelltranscriptomemaps pages 5-6): Bumsik Cho, Sang-Ho Yoon, Daewon Lee, Ferdinand Koranteng, Sudhir Gopal Tattikota, Nuri Cha, Mingyu Shin, Hobin Do, Yanhui Hu, Sue Young Oh, Daehan Lee, A. Vipin Menon, Seok Jun Moon, Norbert Perrimon, Jin-Wu Nam, and Jiwon Shim. Single-cell transcriptome maps of myeloid blood cell lineages in drosophila. Sep 2020. URL: https://doi.org/10.1038/s41467-020-18135-y, doi:10.1038/s41467-020-18135-y. This article has 176 citations and is from a highest quality peer-reviewed journal.
(kharrat2022peelingbackthe pages 6-7): Bayan Kharrat, Gábor Csordás, and Viktor Honti. Peeling back the layers of lymph gland structure and regulation. Jul 2022. URL: https://doi.org/10.3390/ijms23147767, doi:10.3390/ijms23147767. This article has 24 citations.
(carr2024twoubiquitousaldoketo pages 3-5): Samuel C. Carr, Fasih Rehman, Jillian M. Hagel, Xue Chen, Kenneth K. S. Ng, and Peter J. Facchini. Two ubiquitous aldo-keto reductases in the genus papaver support a patchwork model for morphine pathway evolution. Communications Biology, Oct 2024. URL: https://doi.org/10.1038/s42003-024-07100-w, doi:10.1038/s42003-024-07100-w. This article has 10 citations and is from a peer-reviewed journal.
(xiao2024athreelevelregulatory pages 1-2): Zhihong Xiao, Jinyin Zha, Xu Yang, Tingting Huang, Shu-chao Huang, Qi Liu, Xiaozheng Wang, Jie Zhong, Jianting Zheng, Rubing Liang, Zixin Deng, Jian Zhang, Shuangjun Lin, and Shaobo Dai. A three-level regulatory mechanism of the aldo-keto reductase subfamily akr12d. Nature Communications, Mar 2024. URL: https://doi.org/10.1038/s41467-024-46363-z, doi:10.1038/s41467-024-46363-z. This article has 11 citations and is from a highest quality peer-reviewed journal.
(abraham2024structuralandfunctional pages 131-138): N Abraham. Structural and functional studies of oxidoreductases involved in the detoxification of mycotoxins. Unknown journal, 2024.
(xiao2024athreelevelregulatory pages 3-4): Zhihong Xiao, Jinyin Zha, Xu Yang, Tingting Huang, Shu-chao Huang, Qi Liu, Xiaozheng Wang, Jie Zhong, Jianting Zheng, Rubing Liang, Zixin Deng, Jian Zhang, Shuangjun Lin, and Shaobo Dai. A three-level regulatory mechanism of the aldo-keto reductase subfamily akr12d. Nature Communications, Mar 2024. URL: https://doi.org/10.1038/s41467-024-46363-z, doi:10.1038/s41467-024-46363-z. This article has 11 citations and is from a highest quality peer-reviewed journal.
(abraham2024structuralandfunctional pages 41-47): N Abraham. Structural and functional studies of oxidoreductases involved in the detoxification of mycotoxins. Unknown journal, 2024.
(xiao2024athreelevelregulatory pages 2-3): Zhihong Xiao, Jinyin Zha, Xu Yang, Tingting Huang, Shu-chao Huang, Qi Liu, Xiaozheng Wang, Jie Zhong, Jianting Zheng, Rubing Liang, Zixin Deng, Jian Zhang, Shuangjun Lin, and Shaobo Dai. A three-level regulatory mechanism of the aldo-keto reductase subfamily akr12d. Nature Communications, Mar 2024. URL: https://doi.org/10.1038/s41467-024-46363-z, doi:10.1038/s41467-024-46363-z. This article has 11 citations and is from a highest quality peer-reviewed journal.
(diazviraque2023newinsightsinto pages 8-11): Florencia Díaz-Viraqué, María Laura Chiribao, Lisvane Paes-Vieira, Matias R. Machado, Paula Faral-Tello, Ramiro Tomasina, Andrea Trochine, and Carlos Robello. New insights into the role of the trypanosoma cruzi aldo-keto reductase tcakr. Jan 2023. URL: https://doi.org/10.3390/pathogens12010085, doi:10.3390/pathogens12010085. This article has 4 citations.
(cho2020singlecelltranscriptomemaps pages 4-5): Bumsik Cho, Sang-Ho Yoon, Daewon Lee, Ferdinand Koranteng, Sudhir Gopal Tattikota, Nuri Cha, Mingyu Shin, Hobin Do, Yanhui Hu, Sue Young Oh, Daehan Lee, A. Vipin Menon, Seok Jun Moon, Norbert Perrimon, Jin-Wu Nam, and Jiwon Shim. Single-cell transcriptome maps of myeloid blood cell lineages in drosophila. Sep 2020. URL: https://doi.org/10.1038/s41467-020-18135-y, doi:10.1038/s41467-020-18135-y. This article has 176 citations and is from a highest quality peer-reviewed journal.
(stobdan2019highfatdiet pages 6-8): Tsering Stobdan, Debashis Sahoo, Priti Azad, Iain Hartley, Erilynn Heinrichsen, Dan Zhou, and Gabriel G. Haddad. High fat diet induces sex-specific differential gene expression in drosophila melanogaster. PLoS ONE, 14:e0213474, Mar 2019. URL: https://doi.org/10.1371/journal.pone.0213474, doi:10.1371/journal.pone.0213474. This article has 42 citations and is from a peer-reviewed journal.
(chandra2004rolesofimmunoglobulin pages 144-146): S Chandra. Roles of immunoglobulin domain proteins echinoid and friend-of-echinoid in drosophila neurogenesis. Unknown journal, 2004.